ARICI, Bruna
 Distribuzione geografica
Continente #
NA - Nord America 2.439
EU - Europa 2.148
AS - Asia 1.755
SA - Sud America 338
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 36
OC - Oceania 7
AN - Antartide 1
Totale 6.831
Nazione #
US - Stati Uniti d'America 2.360
CN - Cina 660
DE - Germania 630
SG - Singapore 548
PL - Polonia 347
UA - Ucraina 346
BR - Brasile 275
IT - Italia 205
FI - Finlandia 146
HK - Hong Kong 125
FR - Francia 120
IN - India 120
VN - Vietnam 114
RU - Federazione Russa 105
GB - Regno Unito 98
TR - Turchia 61
IE - Irlanda 50
CA - Canada 38
SE - Svezia 33
BD - Bangladesh 27
MX - Messico 27
AR - Argentina 22
BE - Belgio 20
ID - Indonesia 17
EC - Ecuador 13
EU - Europa 13
IQ - Iraq 12
JP - Giappone 10
NL - Olanda 10
PK - Pakistan 10
ZA - Sudafrica 10
ES - Italia 8
AU - Australia 7
PY - Paraguay 7
CO - Colombia 6
SA - Arabia Saudita 6
AT - Austria 5
CZ - Repubblica Ceca 5
IR - Iran 5
KE - Kenya 5
EG - Egitto 4
JO - Giordania 4
NG - Nigeria 4
RO - Romania 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BH - Bahrain 3
CL - Cile 3
CR - Costa Rica 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
NI - Nicaragua 2
OM - Oman 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
CH - Svizzera 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 6.738
Città #
Warsaw 347
Singapore 299
Jacksonville 239
Ashburn 169
Beijing 141
Hong Kong 122
Chandler 115
Fairfield 114
Woodbridge 105
Ann Arbor 102
The Dalles 98
Nanjing 96
Princeton 96
Helsinki 93
San Jose 90
New York 87
Wilmington 82
Houston 77
Cambridge 62
Los Angeles 52
Council Bluffs 51
Dearborn 49
Dublin 49
Columbus 47
Istanbul 45
Seattle 44
Lauterbourg 43
Ho Chi Minh City 38
Brescia 37
Nanchang 35
Munich 34
Buffalo 31
Shenyang 27
Changsha 24
Des Moines 24
São Paulo 24
Tianjin 24
Hebei 22
Milan 21
Jinan 20
Orem 19
San Francisco 18
Brussels 17
Santa Clara 17
Hanoi 16
Pune 16
Jiaxing 15
Toronto 15
Dallas 14
Moscow 14
Shanghai 13
Chicago 12
Dong Ket 12
Lancaster 12
Guangzhou 11
Hangzhou 11
Kocaeli 11
Kunming 11
Mexico City 11
North York 10
San Diego 10
Falkenstein 9
Nürnberg 9
Redondo Beach 9
Rio de Janeiro 9
Atlanta 8
Verona 8
Boardman 7
Brooklyn 7
Dhaka 7
Mumbai 7
Ningbo 7
Phoenix 7
Tokyo 7
Belo Horizonte 6
Chennai 6
Jakarta 6
Johannesburg 6
Rome 6
Turku 6
Zhengzhou 6
Amsterdam 5
Baghdad 5
Charlotte 5
Da Nang 5
Frankfurt am Main 5
Guayaquil 5
Haikou 5
Nuremberg 5
Poplar 5
Taizhou 5
Asunción 4
Cairo 4
Campinas 4
Curitiba 4
Denver 4
Hefei 4
Juiz de Fora 4
London 4
Melbourne 4
Totale 3.789
Nome #
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 324
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 268
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 262
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 238
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 233
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 190
Preparazione di colture primarie di fibroblasti di embrione di pollo . 187
microRNAs and human hepatocellular carcinoma 184
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 176
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 171
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 170
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 154
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 153
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 153
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 142
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 139
Urokinase and c-met are target of miR-23b in human cells. 137
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 134
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 130
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 128
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 128
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 123
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 122
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 122
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 121
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 119
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 119
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 117
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 116
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 116
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 116
Tecniche di conservazione delle cellule mediante congelamento. 115
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 113
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 112
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 112
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 111
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 109
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 108
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 106
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 104
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 101
RNA interference for urokinase gene in human hepatocellular carcinoma 100
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 99
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 97
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 97
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 97
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 95
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 92
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 71
Totale 6.831
Categoria #
all - tutte 28.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022281 0 0 10 26 2 9 10 23 17 35 50 99
2022/2023339 61 13 13 32 31 88 0 24 45 2 15 15
2023/2024361 20 12 28 10 26 90 36 7 72 6 4 50
2024/2025849 2 19 4 117 83 114 44 15 117 33 162 139
2025/20261.576 174 234 131 241 166 111 208 58 90 124 33 6
2026/2027275 89 94 92 0 0 0 0 0 0 0 0 0
Totale 6.831